• By ICR Secretariat
  • Posted Tuesday, November 1, 2022

ICR’s new study tracks disease progression in children with rare type of cancer


Blood tests could help guide the treatment of children with the cancer rhabdomyosarcoma (RMS), according to a new study led by scientists at the Institute of Cancer Research, London (ICR).